Inequities in access to preventative measures, diagnostics and therapeutics in different parts of the world - and in different sectors of the society - impede efforts to eliminate viral hepatitis. This session will feature four talks that will summarize p

Presenter: Holger Willenbring, MD, PhD
Human liver gene therapy with AAV vectors has reached a pivotal stage, marked by the first FDA approval but also fatalities from liver toxicity. Realizing its potential requires transducing hepatocytes or other ther

Presenter: Leslie Saxon, MD
The next era of connected, virtual healthcare will engage users with their data and information and transform the traditional roles assumed in patient care. The big questions and knowledge gaps that be addressed with a digital

(2 of 2 identical workshops offered during TLM 2023)

Part 1: Do we have a level playing field? Addressing inequity in access to liver transplantation

Part 4: Translational aspects of bile acids, intestinal microbiome and the gut-liver-brain axis

Applied Health Informatics is an emerging field that has evolved from using technology principles to collect and store data to a more sophisticated application that strives to ensure data are accurate and used intellectually to ask the right questions and

Part 1: Bile acids: intra-, para- and endocrine hormones

Health disparities in liver disease have long been recognized to affect liver disease morbidity and mortality. There are growing efforts to improve these outcomes for vulnerable populations, but they are often being developed and implemented in silos arou

Part 1: Humanized model systems as tools in liver biology